About
A dynamic, competitive, and results-driven analytical professional with approximately 13 years of experience in Analytical Research & Development, complemented by a strong research background. Holds a Ph.D. in Chemistry, with a proven track record of innovation demonstrated through 2 patents and over 50 scientific publications.
Possesses extensive leadership expertise across a broad spectrum of pharmaceutical formulations and advanced drug delivery technologies, including eyelid wipes, liposomes, micelles, nanoparticles, and peptides. Brings comprehensive experience in handling diverse dosage forms such as injectables, ophthalmic and nasal solutions, oral liquids (syrups, solutions, suspensions), and oral solids (tablets, hard and soft gelatin capsules, and sublingual tablets).
Recognized as a multidisciplinary and highly adaptable professional, capable of managing multiple priorities effectively while consistently aligning with organizational vision and delivering results within stringent timelines.
Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (27)
- A Sustainable LC–MS Method for Determination of Genotoxic Impurity 1-(2-chloroacetyl)pyrrolidine-2-carboxamide (CAPCA): Assessment by Advanced Green Analytical Metrics Save
- Quantification of 24 inorganic impurities in vismodegib and idelalisib anticancer drug substances using ICP-MS Save
- Quality-by-Design-Driven RP-HPLC Method Development and Validation for Impurity Analysis of Elexacaftor, a Cystic Fibrosis Drug, with LC-MS/MS-Based Degradant Identification Save
- Headspace Gas Chromatography–Mass Spectrometry Method for Determination of Class-I Residual Solvents in Several Drug Substances: Method Evaluation by Quality by Design Statistical Tool Save
- Quantification of Drospirenone- and Ethinyl Estradiol-Related Impurities in a Combined Pharmaceutical Dosage Form by a Chromatography Method With a QbD Robustness Study Save
- A quality‐by‐design evaluated liquid chromatography method development and validation for the separation and quantification of nitroxoline and its impurities Save
- Stability-Indicating RP-HPLC Method Development and Validation for Eltrombopag Olamine in the Presence of Impurities and Degradation Products. Robustness by Design of Expert Software Save
- Eco-friendly RP-HPLC UV Quantification Method for Parental Products Buffer Agents by Utilizing Polymethacrylate Resin Stationary Phase in Light of Quality by Design Save
- Determination and quantification of related substances and degradation products in bictegravir by full factorial design evaluated HPLC and mass spectrometry Save
- QbD‐based stability‐indicating liquid chromatography (RP‐HPLC) method for the determination of flurbiprofen in cataplasm Save